Patents by Inventor Henri Klein

Henri Klein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210055002
    Abstract: A filter device for a fume extraction device includes at least two filter elements arranged at an angle relative to one another, and a holding frame for holding the at least two filter elements. An edge of one of the at least two filter elements lies adjacent to an edge of the other one of the at least two filter element. Each of the at least two filter elements has a surface with a variable distance between opposite outer faces of the filter element.
    Type: Application
    Filed: April 8, 2019
    Publication date: February 25, 2021
    Inventors: Aurélien Chartrel, Henri Klein, Florent Lagorgette, Guillaume Laurent
  • Publication number: 20200408441
    Abstract: A table fan includes a fan generating a flow of air, a cleaning device including a circulation system for guiding cleaning liquid in a cleaning circuit, a filter chamber having a suction opening via which air is suctioned downwards, and a filter element arranged in the filter chamber and having at least one portion which is located in the cleaning circuit.
    Type: Application
    Filed: February 18, 2019
    Publication date: December 31, 2020
    Inventors: Sebastien Flesch, Jeremy Jellimann, Henri Klein
  • Patent number: 10155429
    Abstract: An air-conditioning system for air-conditioning an interior of a vehicle may include a fan for driving air. The system may include a control device that may include a circulating air inlet for drawing in circulating air from the interior, a fresh air inlet for drawing in fresh air from an environment of the vehicle, and an air outlet. The control device may include a control valve adjustable between a circulating position and a fresh air position. The control valve may include at least one non-return check valve. The non-return check valve may permit a flow to pass through the control valve in one direction and block the flow in an opposite direction.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: December 18, 2018
    Assignee: Mahle Behr France Rouffach SAS
    Inventors: Henri Klein, Emmanuel Fleith
  • Publication number: 20150147950
    Abstract: An air-conditioning system for air-conditioning an interior of a vehicle may include a fan for driving air. The system may include a control device that may include a circulating air inlet for drawing in circulating air from the interior, a fresh air inlet for drawing in fresh air from an environment of the vehicle, and an air outlet. The control device may include a control valve adjustable between a circulating position and a fresh air position. The control valve may include at least one non-return check valve. The non-return check valve may permit a flow to pass through the control valve in one direction and block the flow in an opposite direction.
    Type: Application
    Filed: November 25, 2014
    Publication date: May 28, 2015
    Inventors: Henri Klein, Emmanuel Fleith
  • Patent number: 7546868
    Abstract: An air conditioner housing having an evaporation device, a heating device, an air control device, an interior space in which air flow paths are formed, and having a housing which surrounds the interior space, is proposed. The air conditioner housing (1) is defined in that a first air flow path (15) and a second air flow path (17) are formed, and in that the air control device (9) has at least two mixing flaps (11, 13), a first mixing flap (11) of which is designed to the first air flow path (15), and a second mixing flap (13) of which is assigned to the second airflow path (17), and in that the mixing flaps (11, 13) each completely open the assigned air flow path (15, 17) in a first functional position and completely close it in a second functional position.
    Type: Grant
    Filed: May 26, 2003
    Date of Patent: June 16, 2009
    Assignees: Behr GmbH & Co. KG, Behr France S.A.R.L.
    Inventors: Henri Klein, Evripidis Koukouravas
  • Patent number: 7484557
    Abstract: An air conditioner housing having an evaporation device, a heating device, an air control device, an interior space in which air flow paths are formed, and having a housing which surrounds the interior space, is proposed. The air conditioner housing (1) is defined in that a first air flow path (15) and a second air flow path (17) are formed, and in that the air control device (9) has at least two mixing flaps (11, 13), a first mixing flap (11) of which is designed to the first air flow path (15), and a second mixing flap (13) of which is assigned to the second airflow path (17), and in that the mixing flaps (11, 13) each completely open the assigned air flow path (15, 17) in a first functional position and completely close it in a second functional position.
    Type: Grant
    Filed: May 26, 2003
    Date of Patent: February 3, 2009
    Assignees: Behr GmbH & Co. KG, Behr France S.A.R.L.
    Inventors: Henri Klein, Evripidis Koukouravas
  • Publication number: 20080035322
    Abstract: The invention relates to a motor vehicle air conditioning unit (1) which is used to temper the front area of a motor vehicle. Said motor vehicle air conditioning unit comprises one first blower (2), an evaporator (4) and a heater (5) and, optionally, an additional heater (6) and an air channel (10) which is used to ventilate the rear. At least one additional, second blower (13) comprising a blower housing (14) is arranged in the air channel (10) which is used to ventilate the rear. Said air channel (10), which is used to ventilate the rear, is a cold air channel.
    Type: Application
    Filed: January 12, 2006
    Publication date: February 14, 2008
    Inventor: Henri Klein
  • Publication number: 20080032617
    Abstract: The invention relates to an air-conditioning unit, in particular, a motor vehicle air-conditioning unit, whereby a part of the housing has a different embodiment for air-conditioning units with differing zones and at least the arrangement of a fan, an evaporator and a heater is the same for the different-zoned air-conditioning units. The housing of the air-conditioning unit may have various embodiments for different versions and/or may be varied by add-on or exchangeable components and, for a multi-zoned embodiment of the air-conditioning unit, a bypass for the floor region is provided in a region of the housing, which diverts from the heater, whereby said bypass is embodied in a region which is redundant in an air-conditioning unit with fewer zones.
    Type: Application
    Filed: September 7, 2005
    Publication date: February 7, 2008
    Applicant: BEHR FRANCE ROUFFACH SAS
    Inventors: Céline Fuentes, Jean-Luc Jesslen, Henri Klein, Eric Ludmann
  • Patent number: 7244589
    Abstract: Multimeric hybrid genes encoding the corresponding chimeric protein comprise a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen. The pathogens particularly are parainfluenza virus (PIV) and respiratory syncytial virus (RSV). A single recombinant immunogen is capable of protecting infants and similar susceptible individuals against diseases caused by both PIV and RSV.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: July 17, 2007
    Assignee: Sanifo Pasteur Limited
    Inventors: Michel Henri Klein, Run-Pan Du, Mary Elizabeth Ewasyshyn
  • Patent number: 7223410
    Abstract: An immunogenic composition capable of producing a respiratory syncytial (RS) virus specific immune response in a host immunized therewith comprises purified, inactivated RS virus which is substantially free from cellular and serum components and which is non-infectious, non-immunopotentiating, immunogenic and protective. The virus is grown on a vaccine quality cell line and harvested virus is purified under non-denaturing conditions to be substantially free from cellular and serum components. The purified RS virus is inactivated using ?-propiolactone, a non-ionic detergent, particularly n-octyl-?-D-glucopyranoside and n-octyl-?-D-glucopyranoside, or ascorbic acid. The immunogenic composition may be formulated as a vaccine for in vivo administration to a human host. The immunogenic composition also may be used in diagnostic applications.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: May 29, 2007
    Assignee: Sanofi Pasteur Limited
    Inventors: Sonia E. Sanhueza, Mary Elizabeth Ewasyshyn, Michel Henri Klein
  • Publication number: 20060090890
    Abstract: An air conditioner housing having an evaporation device, a heating device, an air control device, an interior space in which air flow paths are formed, and having a housing which surrounds the interior space, is proposed. The air conditioner housing (1) is defined in that a first air flow path (15) and a second air flow path (17) are formed, and in that the air control device (9) has at least two mixing flaps (11, 13), a first mixing flap (11) of which is designed to the first air flow path (15), and a second mixing flap (13) of which is assigned to the second airflow path (17), and in that the mixing flaps (11, 13) each completely open the assigned air flow path (15, 17) in a first functional position and completely close it in a second functional position.
    Type: Application
    Filed: May 26, 2003
    Publication date: May 4, 2006
    Inventors: Henri Klein, Evripidis Koukouravas
  • Patent number: 7008784
    Abstract: The present invention is directed toward methods for the production of non-infectious, replication-deficient, immunogenic human immunodeficiency virus (HIV)-like particles. These particles are prepared from a recombinant expression vector comprising a heterologous promoter operatively connected to a DNA molecule comprising a modified HIV genome devoid of the long terminal repeat (LTR) regulatory regions but containing at least the gag and pol genes in their natural genomic arrangement. This vector is introduced into mammalian cells to produce the particles of interest. These particles should prove useful in a number of diagnostic, virologic, and immunologic applications.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: March 7, 2006
    Assignee: Aventis Pasteur Limited
    Inventors: Joel Haynes, Michel Henri Klein, Benjamin Rovinski, Shi Xian Cao
  • Patent number: 6508379
    Abstract: A leak-free drinking beaker comprises a container as well as a lid closing the container, a drink opening which opens into the interior of the container, and a valve extending over the drink opening, which valve is held in the closed position under a certain pretension and can be released against said pretension under the influence of a pressure difference. The valve is a double-acting non-return valve and comprises a flexible valve element and two separate valve seats, the valve element and one of the valve seats has a blocking action in a direction opposed to the direction in which the valve element has a blocking action with the other valve seat.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: January 21, 2003
    Inventors: Henriette Hermine Titia Van De Pol-Klein Nagelvoort, Jan Albert Henri Klein Nagelvoort, Alberthe Joan Klein Nagelvoort, Henri Jan Albert Klein Nagelvoort
  • Patent number: 6455050
    Abstract: Immunogenic envelope glycoproteins are produced from enveloped virus, such as of the paramyxoviridae family, particularly PIV-3 and RSV, by culturing the virus in the substantial absence of exogenous serum proteins, isolating the virus from the tissue culture, solubilizing the envelope glycoproteins and isolating the solubilized envelope glycoproteins by chromatography.
    Type: Grant
    Filed: April 26, 1995
    Date of Patent: September 24, 2002
    Assignee: Aventis Pasteur Limited
    Inventors: Mary Elizabeth Ewasyshyn, Barry Ian Caplan, Anne-Marie Bonneau, Michel Henri Klein
  • Patent number: 6395469
    Abstract: An immunogenic composition capable of producing a respiratory syncytial (RS) virus specific immune response in a host immunized therewith comprises purified, inactivated RS virus which is substantially free from cellular and serum components and which is non-infectious, non-immunopotentiating, immunogenic and protective. The virus is grown on a vaccine quality cell line and harvested virus is purified under non-denaturing conditions to be substantially free from cellular and serum components. The purified RS virus is inactivated using &bgr;-propiolactone, a non-ionic detergent, particularly n-octyl-&agr;-D-glucopyranoside and n-octyl-&bgr;D-glucopyranoside, or ascorbic acid. The immunogenic composition may be formulated as a vaccine for in vivo administration to a human host. The immunogenic composition also may be used in diagnostic applications.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 28, 2002
    Assignee: Aventis Pasteur Limited
    Inventors: Sonia E. Sanhueza, Mary Elizabeth Ewasyshyn, Michel Henri Klein
  • Patent number: 6329512
    Abstract: Immunogenic conjugate molecules comprising at least a portion of a capsular polysaccharide of a Streptococcus strain linked to at least a portion of an outer membrane protein of a Haemophilus strain are provided in which the immunogenicity of the capsular polysaccharide is increased. Particularly capsular polysaccharide from Streptococcus pneumoniae are linked to an outer membrane protein of a Haemophilus influenzae strain, which protein may be the P1, P2 or particularly the P6 outer membrane protein. Conjugate molecules comprising the P6 protein linked to a capsular polysaccharide from an encapsulated pathogen other than Streptococcus also are described, in which the immunogenicity of the capsular polysaccharide is enhanced. Such conjugate molecules may be incorporated into immunogenic compositions for protecting a host against disease caused by the Streptococcus strain and preferably also the Haemophilus strain.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 11, 2001
    Assignee: Aventis Pasteur Limited
    Inventors: Yan-Ping Yang, Ali Kandil, Lucy Gisonni, Raafat Emil Fahmy Fahim, Michel Henri Klein
  • Patent number: 6306637
    Abstract: Immunogenic envelope glycoproteins are produced from enveloped virus, such as of the paramyxoviridae family, particularly PIV-3 and RSV, by culturing the virus in the substantial absence of exogenous serum proteins, isolating the virus from the tissue culture, solubilizing the envelope glycoproteins and isolating the solubilized envelope glycoproteins by chromatography.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 23, 2001
    Assignee: Connaught Laboratories Limited
    Inventors: Mary Elizabeth Ewasyshyn, Barry Ian Caplan, Anne-Marie Bonneau, Michel Henri Klein
  • Patent number: 6291227
    Abstract: An immunogenic retrovirus-like particle which is non-infectious and non-replicating and which is useful as a candidate vaccine component against retroviral infections, including AIDS and ATLL, is produced by genetic engineering. A DNA molecule comprising a retroviral genome devoid of long terminal repeats is incorporated into an expression vector, which is introduced into mammalian cells for expression of the retrovirus-like particle.
    Type: Grant
    Filed: March 9, 1995
    Date of Patent: September 18, 2001
    Assignee: Aventis Pasteur Limited
    Inventors: Joel Haynes, Michel Henri Klein, Benjamin Rovinski, Shi Xian Cao
  • Patent number: 6245549
    Abstract: Immunogenic envelope glycoproteins are produced from enveloped virus, such as of the paramyxoviridae family, particularly PIV-3 and RSV, by culturing the virus in the substantial absence of exogenous serum proteins, isolating the virus from the tissue culture, solubilizing the envelope glycoproteins and isolating the solubilized envelope glycoproteins by chromatography.
    Type: Grant
    Filed: November 25, 1991
    Date of Patent: June 12, 2001
    Assignee: Connaught Laboratories Limited
    Inventors: Mary Elizabeth Ewasyshyn, Barry Ian Caplan, Anne-Marie Bonneau, Michel Henri Klein
  • Patent number: 6177085
    Abstract: Immunogenic conjugate molecules comprising at least a portion of a capsular polysaccharide of a Streptococcus strain linked to at least a portion of an outer membrane protein of a Haemophilus strain are provided in which the immunogenicity of the capsular polysaccharide is increased. Particularly capsular polysaccharide from Streptococcus pneumoniae are linked to an outer membrane protein of a Haemophilus influenzae strain, which protein may be the P1, P2 or particularly the P6 outer membrane protein. Conjugate molecules comprising the P6 protein linked to a capsular polysaccharide from an encapsulated pathogen other than Streptococcus also are described, in which the immunogenicity of the capsular polysaccharide is enhanced. Such conjugate molecules may be incorporated into immunogenic compositions for protecting a host against disease caused by the Streptococcus strain and preferably also the Haemophilus strain.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 23, 2001
    Assignee: Connaught Laboratories Limited
    Inventors: Yan-ping Yang, Ali Kandil, Lucy Gisonni, Raafat Emil Fahmy Fahim, Michel Henri Klein